Haw Par Stock Net Income

HAWPF Stock  USD 12.45  0.00  0.00%   
As of the 9th of February, Haw ParLimited retains the Market Risk Adjusted Performance of 1.55, standard deviation of 1.9, and Risk Adjusted Performance of 0.1204. Haw ParLimited technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Haw ParLimited market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Haw ParLimited is priced fairly, providing market reflects its last-minute price of 12.45 per share. Given that Haw Par has variance of 3.59, we strongly advise you to confirm Haw ParLimited's regular market performance to make sure the company can sustain itself at a future point.
Haw ParLimited's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Haw ParLimited's valuation are provided below:
Haw Par does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Please note, there is a significant difference between Haw ParLimited's value and its price as these two are different measures arrived at by different means. Investors typically determine if Haw ParLimited is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Haw ParLimited's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Haw ParLimited 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Haw ParLimited's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Haw ParLimited.
0.00
11/11/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/09/2026
0.00
If you would invest  0.00  in Haw ParLimited on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Haw Par or generate 0.0% return on investment in Haw ParLimited over 90 days. Haw ParLimited is related to or competes with Virbac SA, HUTCHMED (China), Dermapharm Holding, Sihuan Pharmaceutical, Curaleaf Holdings, and Aspen Pharmacare. Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in... More

Haw ParLimited Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Haw ParLimited's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Haw Par upside and downside potential and time the market with a certain degree of confidence.

Haw ParLimited Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Haw ParLimited's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Haw ParLimited's standard deviation. In reality, there are many statistical measures that can use Haw ParLimited historical prices to predict the future Haw ParLimited's volatility.
Hype
Prediction
LowEstimatedHigh
10.5512.4514.35
Details
Intrinsic
Valuation
LowRealHigh
11.7813.6815.58
Details

Haw ParLimited February 9, 2026 Technical Indicators

Haw ParLimited Backtested Returns

Haw ParLimited appears to be not too volatile, given 3 months investment horizon. Haw ParLimited holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for Haw ParLimited, which you can use to evaluate the volatility of the firm. Please utilize Haw ParLimited's Market Risk Adjusted Performance of 1.55, standard deviation of 1.9, and Risk Adjusted Performance of 0.1204 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Haw ParLimited holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 0.17, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Haw ParLimited's returns are expected to increase less than the market. However, during the bear market, the loss of holding Haw ParLimited is expected to be smaller as well. Please check Haw ParLimited's variance, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Haw ParLimited's current trending patterns will revert.

Auto-correlation

    
  Huge  

Perfect predictability

Haw Par has perfect predictability. Overlapping area represents the amount of predictability between Haw ParLimited time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Haw ParLimited price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current Haw ParLimited price fluctuation can be explain by its past prices.
Correlation Coefficient92233.7 T
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.01
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Haw Par reported net income of 110.1 M. This is 67.74% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The net income for all United States stocks is 80.72% higher than that of the company.

Haw Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Haw ParLimited's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Haw ParLimited could also be used in its relative valuation, which is a method of valuing Haw ParLimited by comparing valuation metrics of similar companies.
Haw Par is currently under evaluation in net income category among its peers.

Haw Fundamentals

About Haw ParLimited Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Haw Par's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Haw ParLimited using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Haw Par based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Haw Pink Sheet

Haw ParLimited financial ratios help investors to determine whether Haw Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haw with respect to the benefits of owning Haw ParLimited security.